Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NanoVibronix, Inc. - Common Stock (NQ: NAOV )

0.5150 -0.0305 (-5.59%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 286,327
Open 0.5600
Bid (Size) 0.5105 (1)
Ask (Size) 0.5339 (2)
Prev. Close 0.5455
Today's Range 0.5030 - 0.5920
52wk Range 0.4550 - 1.520
Shares Outstanding 3,752,354
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire

Performance

YTD
-16.94%
-16.94%
1 Month
-14.17%
-14.17%
3 Month
-11.97%
-11.97%
6 Month
-32.19%
-32.19%
1 Year
-43.41%
-43.41%

More News

Read More
NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement
From NanoVibronix, Inc.
Via Business Wire
NAOV Stock Earnings: NanoVibronix Reported Results for Q2 2024
Via InvestorPlace
NAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024
Via InvestorPlace
NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023
Via InvestorPlace
NanoVibronix Provides Business Update
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Signs Letter of Intent with Potential New Distributor
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Issues Letter to Stockholders
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Issues Letter to Stockholders
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
NanoVibronix Featured in Your Bladder Health Magazine
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Regains Nasdaq Compliance
From NanoVibronix, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.